Merck KGaA banner

Gross Margin

58.7%
Current
Declining
by 0.8%
vs 3-y average of 59.5%

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
58.7%
=
Gross Profit
€12.5B
/
Revenue
€21.3B

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
58.7%
=
Gross Profit
€12.5B
/
Revenue
€21.3B

Peer Comparison

Country Company Market Cap Gross
Margin
DE
Merck KGaA
XETRA:MRK
54.6B EUR
Loading...
US
Thermo Fisher Scientific Inc
NYSE:TMO
195.3B USD
Loading...
US
Danaher Corp
NYSE:DHR
147.9B USD
Loading...
DE
Basf Se
XETRA:BAS
42.5B EUR
Loading...
US
Eli Lilly and Co
NYSE:LLY
986.9B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
596.5B USD
Loading...
CH
Roche Holding AG
SIX:ROG
283.9B CHF
Loading...
CH
Novartis AG
SIX:NOVN
247.6B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
238.1B GBP
Loading...
US
Merck & Co Inc
NYSE:MRK
305.9B USD
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...

Market Distribution

In line with most companies in Germany
Percentile
68th
Based on 3 457 companies
68th percentile
58.7%
Low
-5 776.5% — 29.1%
Typical Range
29.1% — 60.9%
High
60.9% — 184.7%
Distribution Statistics
Germany
Min -5 776.5%
30th Percentile 29.1%
Median 44.6%
70th Percentile 60.9%
Max 184.7%

Merck KGaA
Glance View

In the heart of Darmstadt, Germany, Merck KGaA stands as a testament to innovation and resilience, tracing its roots back to 1668. A bastion of scientific advancement and a pioneer in the world of chemistry and pharmaceuticals, Merck has evolved through centuries of discovery and transformation. Originally a humble pharmacy, Merck has grown into a global powerhouse with a unique structure, being one of the oldest pharmaceutical and chemical companies in the world still owned by the founding family. Though its path has been influenced by numerous historical events, Merck has adeptly navigated the shifting sands of time, transforming itself into a multifaceted conglomerate that thrives on its dual strategy—life sciences and performance materials. In the modern age, Merck KGaA operates through three well-defined sectors: Healthcare, Life Science, and Electronics. Its Healthcare division plays a formidable role, developing innovative drugs, with a focus on oncology, neurology, and immunology, providing cutting-edge treatments that improve patient lives globally. Meanwhile, the Life Science arm caters to researchers and scientists, offering an extensive portfolio of lab materials, high-tech tools, and equipment essential for groundbreaking research across various industries. The Electronics division, dedicated to performance materials, supplies high-quality substances crucial for the electronics and automotive industries, including liquid crystals and highly sophisticated semiconductor solutions. Through these divisions, Merck KGaA not only generates substantial revenue but also drives progress by supplying critical products that are indispensable to the modern technological landscape.

MRK Intrinsic Value
172.43 EUR
Undervaluation 8%
Intrinsic Value
Price
What is Gross Margin?
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
How is Gross Margin calculated?

Gross Margin is calculated by dividing the Gross Profit by the Revenue.

Gross Margin
58.7%
=
Gross Profit
€12.5B
/
Revenue
€21.3B
What is Merck KGaA's current Gross Margin?

The current Gross Margin for Merck KGaA is 58.7%, which is below its 3-year median of 59.5%.

How has Gross Margin changed over time?

Over the last 3 years, Merck KGaA’s Gross Margin has decreased from 62.4% to 58.7%. During this period, it reached a low of 58% on Mar 31, 2024 and a high of 62.4% on Sep 30, 2022.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett